HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.

AuthorsK L Johansen
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 24 Issue 4 Pg. 183-5 (Apr 2001) ISSN: 0391-3988 [Print] United States
PMID11394696 (Publication Type: Editorial, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anabolic Agents
  • Erythropoietin
  • Nandrolone
Topics
  • Anabolic Agents (pharmacology, therapeutic use)
  • Anemia (drug therapy, etiology)
  • Body Composition
  • Erythropoietin (therapeutic use)
  • Female
  • Hematocrit
  • Humans
  • Kidney Failure, Chronic (complications, therapy)
  • Male
  • Nandrolone (pharmacology, therapeutic use)
  • Physical Exertion (physiology)
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: